DrugPatentWatch Database Preview
Patent: 5,616,560
» See Plans and Pricing
Summary for Patent: 5,616,560
| Title: | Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone |
| Abstract: | The present invention provides methods of increasing bone mass in a human or other animal subject afflicted with osteoporosis, comprising a thirty(30)-day treatment period, comprised of a parathyroid hormone administration regimen and a bisphosphonate administration regimen, wherein (a) said parathyroid hormone administration regimen comprises the administration to said subject of parathyroid hormone at one or more level of from about 4 IU/kg per day to about 15 IU/kg per day that said parathyroid hormone is administered, provided that said parathyroid hormone is administered at least one day every seven days of every said thirty(30)-day treatment periods; and wherein (b) said bisphosphonate administration regimen comprises the administration to said subject of a bisphosphonate at a level of from about 0.0005 mgP/kg to about 1.0 mgP/kg per day that said bisphosphonate is administered, provided that said bisphosphonate is administered at least 1 day of every said thirty(30)-day treatment period. |
| Inventor(s): | Geddes; Ann D. (Norwich, NY), Boyce; Rogely W. (Pottstown, PA) |
| Assignee: | The Procter & Gamble Company (Cincinnati, OH) |
| Application Number: | 08/619,103 |
| Patent Claims: | see list of patent claims |
Details for Patent 5,616,560
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 004 | 2015-01-23 | Start Trial | The Procter & Gamble Company (Cincinnati, OH) | 2011-12-17 | RX | Orphan | search |
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 003 | 2015-01-23 | Start Trial | The Procter & Gamble Company (Cincinnati, OH) | 2011-12-17 | RX | Orphan | search |
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 002 | 2015-01-23 | Start Trial | The Procter & Gamble Company (Cincinnati, OH) | 2011-12-17 | RX | Orphan | search |
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 001 | 2015-01-23 | Start Trial | The Procter & Gamble Company (Cincinnati, OH) | 2011-12-17 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 5,616,560
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Africa | 929758 | Start Trial |
| World Intellectual Property Organization (WIPO) | 9311786 | Start Trial |
| Slovakia | 74594 | Start Trial |
| Russian Federation | 2104699 | Start Trial |
| Russian Federation | 2112515 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
